Sponsor:
Dana-Farber Cancer Institute
Code:
NCT04968834
Conditions
Leukemia
Myelodysplastic Syndromes
Myeloproliferative Syndrome
Eligibility Criteria
Sex: All
Age: 0 - 30
Healthy Volunteers: Not accepted
Interventions
Genomic profiling
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Dana-Farber Cancer Institute on 2024-11-05.